A real-world study based on the FAERS database evaluating adverse drug reactions in three amphotericin B lipid formulations

Background: Amphotericin B (AmB) remains the cornerstone in the treatment of severe fungal infections. However, selecting an appropriate lipid-based formulation for different clinical scenarios remains a challenge for clinicians and clinical pharmacists.Methods: Adverse event (AE) reports from the F...

Full description

Saved in:
Bibliographic Details
Main Authors: Binliang Tong, Jiaqi Wang, Yanjing Zhang, Yan Liu, Jing Wang, Liguang Duan, Yuhang Yan, Qixuan Sun, Yueyao Luan, Jing Yu, Chunhua Zhou
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Journal of Pharmaceutical Policy and Practice
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/20523211.2025.2514155
Tags: Add Tag
No Tags, Be the first to tag this record!